Salaires et Rémunération chez Denali Therapeutics
Tech
Denali Therapeutics is a US-based biopharmaceutical company that develops therapeutic candidates for neurodegenerative diseases. Its product candidates include LRRK2 inhibitor, DNL310, DNL343, AR443820/DNL788, and SAR443122/DNL758. The company has collaboration agreements with various pharmaceutical companies and research institutions. It was formerly known as SPR Pharma Inc. and was incorporated in 2013.
Siège social:South San Francisco, United States
Fondée en:2015
Employés:201-1,000
Type:public
Revenu estimé:$100M-$250M
4
Salaires enregistrés
$150K
Rémunération totale moy.
$125K
Rémunération totale médiane
USD
Devise
Statistiques en USD (converties). Sélectionnez un pays pour des chiffres locaux précis.
Siège social